真人做爰48姿势视图片|少妇真人直播免费视频|日本真人做爰A片|真人裸体做爰视频|真人与拘做爰视频免费观看|真人与拘做受免费视频一

穿孔素1(PRF1)重組蛋白

Recombinant Perforin 1 (PRF1)

FLH2; HPLH2; P1; PFP; Pore Forming Protein; Cytolysin; Lymphocyte pore-forming protein

  • 穿孔素1(PRF1)重組蛋白 產(chǎn)品包裝(模擬)
  • 穿孔素1(PRF1)重組蛋白 產(chǎn)品包裝(模擬)
  • 穿孔素1(PRF1)重組蛋白 Figure . Gene Sequencing (extract)
  • RPB317Mu01.jpg Figure. SDS-PAGE
  • Certificate 通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

序列

用法

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

儲(chǔ)存

避免反復(fù)凍融。2-8°C不超過一個(gè)月,-80°C不超過12個(gè)月。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。

相關(guān)產(chǎn)品

編號(hào) 適用物種:Mus musculus (Mouse,小鼠) 應(yīng)用(僅供研究使用,不用于臨床診斷!)
RPB317Mu01 穿孔素1(PRF1)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
RPB317Mu02 穿孔素1(PRF1)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
APB317Mu01 穿孔素1(PRF1)活性蛋白 Cell?culture;?Activity?Assays.
APB317Mu02 穿孔素1(PRF1)活性蛋白 Cell?culture;?Activity?Assays.
PAB317Mu01 穿孔素1(PRF1)多克隆抗體 WB; IHC; ICC; IP.
PAB317Mu02 穿孔素1(PRF1)多克隆抗體 WB; IHC; ICC; IP.
LAB317Mu81 穿孔素1(PRF1)多克隆抗體(異硫氰酸熒光素標(biāo)記) WB; IHC; ICC; IF.
LAB317Mu71 穿孔素1(PRF1)多克隆抗體(生物素標(biāo)記) WB; IHC; ICC.
WEB317Mu 穿孔素1(PRF1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,寬范圍) Enzyme-linked immunosorbent assay for Antigen Detection.
SEB317Mu 穿孔素1(PRF1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB317Mu 穿孔素1(PRF1)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) FLIA Kit for Antigen Detection.

參考文獻(xiàn)

雜志 參考文獻(xiàn)
Diagnostic Microbiology and Infectious Disease Granzyme B as a diagnostic marker of tuberculosis in patients with and without HIV coinfection [Pubmed:26915636]
FASEB?JOURNAL The immunoregulatory effects of CD8 T-cell–derived perforin on diet-induced nonalcoholic steatohepatitis [Pubmed: 30951375]
Theranostics A novel Granzyme B nanoparticle delivery system simulates immune cell functions for suppression of solid tumors [Pubmed: 31695790]
Mol Immunol CD317 mediates immunocytolysis resistance by RICH2/cytoskeleton-dependent membrane protection [Pubmed: 33223223]
INVESTIGATIONAL NEW DRUGS Dual-function chimeric antigen receptor T cells targeting c-Met and PD-1 exhibit potent anti-tumor efficacy in solid tumors [Pubmed: 32772342]
Am J Transl Res Combined treatment with epigenetic agents enhances anti-tumor activity of T cells by upregulating the ACRBP expression in hepatocellular carcinoma [34377237]
Nat Biomed Eng Cancer-cell stiffening via cholesterol depletion enhances adoptive T-cell immunotherapy [34873307]
J Exp Med Single-cell immune profiling reveals functional diversity of T cells in tuberculous pleural effusion [Pubmed:35061012]
留言咨詢
五常市| 凤冈县| 郧西县| 东港市| 沈丘县| 玉屏| 南木林县| 上蔡县| 湛江市| 通海县| 新源县| 永泰县| 中西区| 平顶山市| 郴州市| 越西县| 延安市| 潼南县| 同德县| 和政县| 泽州县| 望都县| 盐津县| 三门县| 申扎县| 麻江县| 建始县| 漳平市| 巨鹿县| 县级市| 定安县| 连南| 垦利县| 嘉祥县| 安徽省| 蒲城县| 邢台市| 九龙县| 西吉县| 剑川县| 楚雄市|